{"nct_id":"NCT03600883","title":"A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-10","start_date":"2018-08-27","start_date_type":"ACTUAL","primary_completion_date":"2026-01-31","primary_completion_date_type":"ESTIMATED","completion_date":"2026-01-31","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["AMGN"]}